Skip to main content

T-Pred FDA Approval Status

FDA Approved: No
Brand name: T-Pred
Generic name: tobramycin and prednisolone
Dosage form: Ophthalmic Suspension
Company: ISTA Pharmaceuticals, Inc.
Treatment for: Ocular Inflammation

Development timeline for T-Pred

May  4, 2007ISTA Provides Regulatory Update on T-Pred NDA Filing
Jul  6, 2006ISTA Pharmaceuticals Files NDA for T-Pred

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.